ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: However, in CML, BCR-ABL a fusion protein via the increasing de-ubiquitinating activity of HAUSP toward PTEN could interfere with PTEN by promoting its removal from the cell nucleus.